Clinical Trials Directory

Trials / Unknown

UnknownNCT03806075

Study of Accurate Diagnosis and Treatment of Peutz-Jeghers Syndrome

Molecular Typing and Precise Prevention and Treatment of Peutz-Jeghers Syndrome

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
150 (estimated)
Sponsor
Yiqi Du · Academic / Other
Sex
All
Age
5 Years – 70 Years
Healthy volunteers
Accepted

Summary

The mutation of STK11 has been regcognized to be the major cause of Peutz-Jeghers syndrome (PJS).The aim of this study was to confirm the mutation rate of gene associated with gastrointestinal malignancies,including STK11, APC,PMS1,et al. Furtherly, the investigators analyze the association of STK11 with gut microbiota.

Detailed description

All patients diagnosed as PJS were enrolled and accepted second generation gene sequencing with their blood specimens. Then all patients allocated into gene mutation group and no gene mutation group according to if the cases accompany with gene mutation of STK11.Also, health persons were enrolled and a case controlled study will be carried out.All patients and health persons accepted 16s rRNA sequencing with their feces specimens.

Conditions

Interventions

TypeNameDescription
BEHAVIORALSecond generation sequencingFirstly, all Peutz-Jeghers patients accept second generation gene sequencing with their blood specimen
BEHAVIORAL16s rRNA gene sequencingSecondly, All patients and Health persons accepted 16s rRNA gene sequencing with their feces specimen

Timeline

Start date
2018-03-01
Primary completion
2021-09-01
Completion
2021-09-01
First posted
2019-01-16
Last updated
2019-01-16

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03806075. Inclusion in this directory is not an endorsement.

Study of Accurate Diagnosis and Treatment of Peutz-Jeghers Syndrome (NCT03806075) · Clinical Trials Directory